Advertisement

Topics

Samsung Looks Beyond Biosimilars Via Takeda Tie-Up

04:33 EDT 21 Aug 2017 | SCRIP

Samsung Bioepis is shifting gears moving into the development of novel biologics via a strategic collaboration with Takeda. The partners...

      

Related Stories

 

Original Article: Samsung Looks Beyond Biosimilars Via Takeda Tie-Up

NEXT ARTICLE

More From BioPortfolio on "Samsung Looks Beyond Biosimilars Via Takeda Tie-Up"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...